1.159
전일 마감가:
$1.15
열려 있는:
$1.14
하루 거래량:
39,807
Relative Volume:
0.24
시가총액:
$13.41M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-2.1868
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
-7.04%
1개월 성능:
+8.37%
6개월 성능:
-18.17%
1년 성능:
-25.03%
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TXMD
Therapeuticsmd Inc
|
1.159 | 13.31M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
124.84 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.58 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.335 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.40 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.31 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 개시 | Guggenheim | Buy |
| 2019-10-17 | 개시 | H.C. Wainwright | Buy |
| 2019-04-30 | 재개 | Noble Capital Markets | Outperform |
| 2018-06-15 | 개시 | JP Morgan | Overweight |
| 2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 재개 | Jefferies | Buy |
| 2016-11-22 | 개시 | Oppenheimer | Outperform |
| 2016-11-07 | 재개 | Guggenheim | Buy |
| 2016-04-04 | 개시 | Goldman | Buy |
| 2015-12-08 | 재확인 | Jefferies | Buy |
| 2015-12-08 | 재확인 | Stifel | Buy |
| 2015-09-21 | 재확인 | Jefferies | Buy |
| 2015-06-09 | 개시 | Guggenheim | Buy |
| 2014-07-08 | 개시 | FBR Capital | Outperform |
| 2014-04-17 | 재확인 | Noble Financial | Buy |
| 2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
How to manage a losing position in TherapeuticsMD Inc.Dividend Hike & Proven Capital Preservation Tips - newser.com
Will TherapeuticsMD Inc. stock see insider buyingJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - newser.com
Can TherapeuticsMD Inc. (29TA) stock test all time highsQuarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com
Will TherapeuticsMD Inc. stock beat EPS estimatesJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
What MACD and RSI say about TherapeuticsMD Inc.July 2025 Summary & Expert Approved Trade Ideas - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationMarket Risk Report & Consistent Income Trade Recommendations - newser.com
Will TherapeuticsMD Inc. stock benefit from upcoming earnings reportsEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recovery2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
How TherapeuticsMD Inc. (29TA) stock correlates with oil marketsEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Can TherapeuticsMD Inc. stock weather global recession2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
Trend analysis for TherapeuticsMD Inc. this week2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com
How to build a dashboard for TherapeuticsMD Inc. stockQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Why TherapeuticsMD Inc. stock is seen as undervaluedWeekly Profit Analysis & Consistent Return Investment Signals - newser.com
Why ETFs are accumulating TherapeuticsMD Inc. (29TA) stock2025 Technical Patterns & Precise Buy Zone Identification - newser.com
Can TherapeuticsMD Inc. stock surprise with earnings upside2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
Key metrics from TherapeuticsMD Inc.’s quarterly dataPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com
How to read the order book for TherapeuticsMD Inc.Weekly Trade Review & Daily Chart Pattern Signals - newser.com
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Therapeuticsmd Inc 주식 (TXMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
자본화:
|
볼륨(24시간):